# Population Admixture and APOB Variant Landscape in Ecuadorian Mestizo Patients with Cardiac Diseases: Potential Implications for Familial Hypercholesterolemia Genetics

**Authors:** Santiago Cadena-Ullauri, Patricia Guevara-Ramírez, Viviana A. Ruiz-Pozo, Rafael Tamayo-Trujillo, Elius Paz-Cruz, Manuel Becerra-Fernández, Nieves Doménech, José Luis Laso-Bayas, Rita Ibarra-Castillo, Alejandro Cabrera-Andrade, Ana Karina Zambrano

PMC · DOI: 10.3390/jcdd13010036 · 2026-01-08

## TL;DR

This study explores APOB gene variants in Ecuadorian mestizo patients with heart conditions, highlighting genetic diversity and the need for regional data in admixed populations.

## Contribution

The study provides the first comprehensive analysis of APOB variants in Ecuadorian mestizos, emphasizing the importance of regional genomic data for admixed populations.

## Key findings

- 227 APOB variants were identified, mostly benign or likely benign.
- APOB variant frequencies in Ecuadorian mestizos align with other Latin American populations.
- No pathogenic APOB variants were detected in the cohort.

## Abstract

Apolipoprotein B (APOB) is a key structural component of atherogenic lipoproteins and one of the principal genes implicated in familial hypercholesterolemia (FH). However, APOB genetic variation remains poorly characterized in Latin American and admixed populations. In this study, we performed a descriptive analysis of APOB variants in 60 Ecuadorian mestizo patients with inherited cardiac conditions using next-generation sequencing (NGS) and genetic ancestry inference. A total of 227 APOB variants were identified, the majority of which were classified as benign (n = 220) or likely benign (n = 3) according to ACMG criteria, while three variants were classified as variants of uncertain significance (VUS). The most frequently observed variants included rs1042034, rs679899, rs676210, and rs1367117. Comparative allele-frequency analyses using ALFA and PAGE Latin American reference datasets demonstrated that the APOB variant frequencies observed in the cohort were comparable to those reported in other Latin American populations, reflecting the admixed genetic background of Ecuadorian mestizos, predominantly of Native American and European ancestry. No pathogenic APOB variants were detected. Although lipid measurements were not available and genotype–phenotype associations could not be assessed, this study provides the first comprehensive overview of APOB variation in Ecuadorian mestizo individuals. These findings expand population-specific genomic data for an underrepresented group and underscore the importance of regional reference datasets for accurate variant interpretation in admixed populations.

## Linked entities

- **Genes:** APOB (apolipoprotein B) [NCBI Gene 338]
- **Diseases:** familial hypercholesterolemia (MONDO:0005439)

## Full-text entities

- **Genes:** APOB (apolipoprotein B) [NCBI Gene 338] {aka FCHL2, FLDB, LDLCQ4, apoB-100, apoB-48}
- **Diseases:** FH (MESH:D006938), atherogenic (MESH:D050197), Cardiac Diseases (MESH:D006331)
- **Chemicals:** lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs676210, rs1042034, rs679899, rs1367117

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12841957/full.md

---
Source: https://tomesphere.com/paper/PMC12841957